Most Clicked StoriesMore >


Company challenges British clinical trial transparency reform

DIA Global SmartBrief | May 21, 2015

Richmond Pharmacology, a company that runs human drug trials for major pharmaceutical firms, has brought a judicial review to challenge a reform proposed by Britain's Health Research Authority that would require registration of all such studies, including those with poor results. The effort toward greater transparency has been a major push of the AllTrials campaign, launched in 2013 by scientists from medical journals and the Cochrane Collaboration. The Guardian (London) (05/18)


AstraZeneca to build $285M biologic facility in Sweden

DIA Global SmartBrief | May 19, 2015

EMA confirms conflict-of-interest policy

DIA Global SmartBrief | May 21, 2015

EU regulators undertake review of medical device notified bodies

DIA Global SmartBrief | May 19, 2015

FDA supports LOINC code use in pharmaceutical, biological submissions

DIA Global SmartBrief | May 21, 2015

No organization connects regulators with professionals whose work they regulate like DIA

DIA Global SmartBrief | May 19, 2015

DIA's comprehensive online eLearning portfolio

DIA Global SmartBrief | May 21, 2015

FDA to examine how generic size, shape affect adherence

DIA Global SmartBrief | May 19, 2015

Lawmakers aim to extend exclusivity of rare disease drugs

DIA Global SmartBrief | May 19, 2015

Court in India blocks sale of generic Merck drugs

DIA Global SmartBrief | May 19, 2015


Find DIA Global SmartBrief Issues by Date:



DIA News More >


DIA's comprehensive online eLearning portfolio

DIA Global SmartBrief | May 21, 2015

No organization connects regulators with professionals whose work they regulate like DIA

DIA Global SmartBrief | May 19, 2015

Thinking globally, acting locally

DIA Global SmartBrief | May 14, 2015

DIA 2015 51st Annual Meeting

DIA Global SmartBrief | May 12, 2015

Tomorrow's 21st Century Cures -- today

DIA Global SmartBrief | May 05, 2015




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more